Literature DB >> 15961400

An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6.

Han Ie Kim1, Seung-Taek Lee.   

Abstract

Protein-tyrosine kinase-6 (PTK6, also known as Brk) is a non-receptor tyrosine kinase that contains SH3, SH2, and catalytic (Kinase) domains. We have identified an intramolecular interaction between the linker (Linker) region connecting the SH2 and Kinase domains and the Kinase domain. Residue Trp-184 within the Linker region is essential for the Linker-Kinase interaction but not for the Linker-SH3 interaction. A recombinant PTK6 Kinase domain connected to the Linker region had catalytic activity in terms of autophosphorylation, phosphorylation of a PTK6 substrate, BKS, and phosphorylation of an oligopeptide substrate, whereas the Kinase domain itself, or one connected to a Linker region containing a W184A substitution, did not. The introduction of the W184A mutation into PTK6 also abrogated autophosphorylation and phosphorylation of another PTK6 substrate, Sam68, as well as phosphorylation of intracellular proteins. It also abolished the ability of PTK6 to promote proliferation and prevent apoptosis of HEK 293 cells, as well as to permit anchorage-independent colony formation. Therefore, unlike Src family members, in which the Linker-Kinase interaction inhibits catalytic activity, in PTK6 this interaction has an essential positive role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15961400     DOI: 10.1074/jbc.M504568200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells.

Authors:  Hye-Won Na; Won-Sik Shin; Andreas Ludwig; Seung-Taek Lee
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  Signature of positive selection of PTK6 gene in East Asian populations: a cross talk for Helicobacter pylori invasion and gastric cancer endemicity.

Authors:  Pankaj Jha; Dongsheng Lu; Yuan Yuan; Shuhua Xu
Journal:  Mol Genet Genomics       Date:  2015-04-03       Impact factor: 3.291

Review 3.  Brk/PTK6 signaling in normal and cancer cell models.

Authors:  Julie H Ostrander; Andrea R Daniel; Carol A Lange
Journal:  Curr Opin Pharmacol       Date:  2010-09-09       Impact factor: 5.547

4.  PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1.

Authors:  Shin-Ae Kang; Eun-Saem Lee; Hye-Young Yoon; Paul A Randazzo; Seung-Taek Lee
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 5.  Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Biochim Biophys Acta       Date:  2010-02-26

6.  The associated pyrazolopyrimidines PP1 and PP2 inhibit protein tyrosine kinase 6 activity and suppress breast cancer cell proliferation.

Authors:  Hyun Jae Shim; Han Ie Kim; Seung-Taek Lee
Journal:  Oncol Lett       Date:  2017-01-02       Impact factor: 2.967

7.  Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.

Authors:  Monika Kasprzycka; Miroslaw Majewski; Zhi-Jong Wang; Andrzej Ptasznik; Maria Wysocka; Qian Zhang; Michal Marzec; Phyllis Gimotty; Mark R Crompton; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.

Authors:  Amanda J Harvey; Caroline J Pennington; Sarah Porter; Rajpal S Burmi; Dylan R Edwards; William Court; Suzanne A Eccles; Mark R Crompton
Journal:  Am J Pathol       Date:  2009-08-06       Impact factor: 4.307

9.  Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo.

Authors:  S Miah; A Martin; K E Lukong
Journal:  Oncogenesis       Date:  2012-05-07       Impact factor: 7.485

10.  Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells.

Authors:  Han Ie Kim; Hyun-Sung Lee; Tae Hyun Kim; Ju-Seog Lee; Seung-Taek Lee; Seo-Jin Lee
Journal:  Oncotarget       Date:  2015-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.